COMING NEXT:

Days
Hours
Min
Sec

DEADLINE EXTENDED

EADV Congress: Submit your abstracts

SUBMIT BY 8 MAY

CLOSING ON 22 APRIL 23:59 CEST

ONLY FEW DAYS LEFT

APPLY BY 1 APRIL

European Academy of Dermatology & Venereology

With over 10'000 members and an active community of more than 15'000 professionals around the world, our goal is to be the trusted source for proven scientific advancements and practices in the prevention, diagnosis, and treatment of skin and venereal diseases.

EADV is committed to building the international community that develops, shares, and adopts best practices within dermatology and venereology.

Skin and venereal diseases are continuously evolving, as are the science and practices for preventing, diagnosing and treating them. Advancements are being made every day that have the potential to have a significant impact on the ongoing battle to improve skin and sexual health around the world.  Enabling these advancements to be validated and ensuring all professionals adopt the best practices ultimately moves dermatology and venereology forward.

EADV and its international community of passionate professionals define and spread best practices in dermatology and venereology for the benefit of all.  We are a true platform for collaboration and progress across borders and sub-specialties.

Expert task forces shape standards and develop best practice guidelines, while our events, publications, and educational courses share them with our members and the broader community so they can adopt them for maximum impact.

Together for better

EADV LATEST NEWS:

JEADV Call for Junior Editors

We are pleased to announce an exciting opportunity to join the Journal of the European Academy of Dermatology and Venereology (JEADV) as Junior Editors for a 4-year term.

This position is ideal for early to mid-career dermatologists with an academic interest.

Submit your complete applications by 15 October 2024.

READ MORE

Vol 3 Issue 2 of the JEACP is online

See the latest updates from JEADV Clinical Practice (JEACP), our open-access publication focused on clinical content and practical information.
In this issue: laser, skin cancer, Mohs surgery, alopecia, and more.

READ MORE

Position statement on latest study regarding benzene in Acne products

Benzene, a highly volatile chemical, poses significant health risks, classified as a Group 1 carcinogen by IARC. Exposure occurs through various sources, including industrial emissions, tobacco smoke, and contaminated cosmetics. Recent findings of benzene in anti-acne products raise concerns, prompting precautionary measures and legal actions.

READ MORE

KEEP IN TOUCH

Stay informed about latest EADV information: 
Congresses, Education, JEADV, Membership, Newsletter.